Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 3/20 | 0.38 |
| ▸ | MAOB | P27338 | 3/20 | 0.38 |
| ▸ | FNTA | P49354 | 2/20 | 0.38 |
| ▸ | FNTB | P49356 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6839890 | 0.83 | L3MBTL1 (0.40) | L3MBTL1LMNAMAPK1HTTNPC1 | |
| SCHEMBL15580126 | 0.78 | NPC1 (0.49) | L3MBTL1LMNAMAPK1HTTNPC1 | |
| SCHEMBL7805644 | 0.74 | CES1 (0.48) | L3MBTL1LMNAMAPK1HTTNPC1 | |
| SCHEMBL7651351 | 0.74 | CES1 (0.48) | L3MBTL1LMNAMAPK1HTTNPC1 | |
| SCHEMBL92110 | 0.71 | SMN1; SMN2 (0.57) | LMNAMAPK1NPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL8858583 | 0.71 | NPC1 (0.42) | L3MBTL1LMNAMAPK1NPC1MAOB | |
| SCHEMBL8858581 | 0.71 | NPC1 (0.42) | L3MBTL1LMNAMAPK1NPC1MAOB | |
| SCHEMBL13424332 | 0.70 | HPGD (0.41) | L3MBTL1LMNAMAPK1HTTNPC1 | |
| SCHEMBL26325460 | 0.69 | CES2 (0.42) | L3MBTL1LMNAMAPK1HTTCES2 | |
| SCHEMBL6025403 | 0.69 | SMN1; SMN2 (0.48) | LMNANPC1CES2CES1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040039220-A1 | Process for the preparation of pesticides | FAROOQ SALEEM (CH) | 2004-02-26 | — | — | US | disclosed |
| US-6646151-B1 | Efficient oximation | BAYER AKTIENGESELLSCHAFT (DE) | 2003-11-11 | — | — | US | disclosed |
| EP-0876333-B1 | PROCESS FOR THE PREPARATION OF PESTICIDES | BAYER AG (DE) | 2002-03-27 | — | — | EP | disclosed |
| US-6156923-A | Process for the preparation of pesticides | NOVARTIS CORPORATION (US) | 2000-12-05 | — | — | US | disclosed |
| EP-0876333-A1 | PROCESS FOR THE PREPARATION OF PESTICIDES | Novartis AG (CH) | 1998-11-11 | — | — | EP | disclosed |
| WO-1997020808-A1 | PROCESS FOR THE PREPARATION OF PESTICIDES | NOVARTIS AG (CH) | 1997-06-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040039220-A1 | Process for the preparation of pesticides | CHRM1, CHRM2, F7 | L3MBTL1 4034/4885LMNA 429/4885MAPK1 1374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.